Fatal case of necrotizing fasciitis due to Myroides odoratus
会阴部坏死性筋膜炎7例临床诊治体会

会阴部坏死性筋膜炎7例临床诊治体会会阴部坏死性筋膜炎(necrotizing fasciitis of the perineum)是一种罕见但危重的感染性疾病,通常发生在男性糖尿病患者或长期使用尿管的患者身上。
在本文中,我将介绍临床上诊断和治疗这种疾病的体会。
1. 早期诊断和治疗是关键会阴部坏死性筋膜炎是一种迅速进展的感染性疾病,未经及时治疗,死亡率接近100%。
因此,早期诊断和治疗是关键。
对于有高危因素的糖尿病患者或长期使用尿管的患者,一旦发现会阴部疼痛、肿胀、红肿、皮肤发热等症状,应立即就医。
2. 必须采取手术治疗会阴部坏死性筋膜炎是一种感染性坏死性病变,必须采取手术治疗。
治疗手段包括肌肉切开、切除坏死组织和必要的固定和引流。
手术过程中要注意清除坏死组织、控制感染以及保护正常组织结构,以确保术后的伤口纵深愈合和功能的恢复。
3. 抗生素治疗同样重要抗生素治疗同样重要,但必须在手术治疗后立即使用。
选择抗生素应根据细菌培养结果及时进行调整。
常见的抗生素包括甲氧西林、头孢类药物、氨基糖苷类药物等。
4. 随访和康复治疗患者治愈后应进行一定的随访和康复治疗。
包括去除糖尿病、戒烟戒酒、饮食调整、定期检查等。
定期医学美容治疗是非常必要的,不仅可以改善局部色素沉着,还能调整局部组织结构使之较为贴近正常。
5. 注意预防对于高危人群,一些预防措施仍然非常必要。
这包括杜绝糖尿病、合理使用尿管、及时治疗泌尿系统感染、保持局部卫生等。
本文总结了我对会阴部坏死性筋膜炎的临床诊治体会。
早期诊断和治疗是关键,手术治疗以及适当的抗生素治疗是必要的。
加强随访和康复治疗,注意预防是非常必要的。
necrosis名词解释

necrosis名词解释necrosis是指细胞或组织的死亡现象。
这种现象通常是由于细胞遭受到严重的损害或释放出的有害物质导致的。
当细胞死亡和组织坏死发生时,常常伴随着炎症反应和细胞碎片的清除。
通常情况下,正常的细胞通过凋亡(apoptosis)方式进行死亡,这是一种程序性的死亡过程,是生命中维持平衡的一部分。
然而,当细胞受到严重的外界刺激,如感染、损伤、缺血等,就可能发生necrosis。
necrosis可以分为多种类型,包括凝固性坏死(coagulative necrosis)、液化性坏死(liquefactive necrosis)、干酪样坏死(caseous necrosis)、脂肪坏死(fat necrosis)和坏死性肝炎(necrotizing hepatitis)等。
每种类型的necrosis都有其独特的特点和形态学表现。
一种常见的necrosis类型是凝固性坏死。
这种坏死通常发生在缺血引起的组织死亡中,其中细胞和组织结构被保留,但细胞内的高度有机化合物,如蛋白质和酶,被破坏。
这使得细胞和组织失去了其特有的形态结构,并呈现出均质的玻璃样外观。
液化性坏死发生在组织受到感染或脑组织缺血时。
这种坏死特征是细胞和组织的溶解,形成液体状。
这是由于炎症反应引起的细胞被溶解的酶的释放,导致组织的流动和快速溶解。
干酪样坏死是一种特殊的坏死类型,常见于结核感染。
这种坏死表现为干酪样的外观,呈现橘黄色或奶酪样的质地。
干酪样坏死由于细胞内和细胞外的物质沉积,导致组织变得松散并形成类似干酪的质地。
脂肪坏死是指当脂肪组织受到急性损伤时发生的坏死。
这种坏死可以由于外伤、化学物质或炎症等多种原因引起。
脂肪坏死的特征是脂肪细胞的破裂和释放脂肪酸,导致周围炎症反应和纤维化。
坏死性肝炎是一种严重的肝脏疾病,主要由于肝脏受到病毒感染或其他损伤导致。
这种坏死表现为广泛的肝细胞死亡和组织坏死,严重影响肝脏的功能。
总之,necrosis是细胞或组织的死亡现象,通常由严重的损伤或有害物质引起。
《中国鲍曼不动杆菌感染诊治与防控专家共识》

万方数据万方数据万方数据万方数据万方数据万方数据万方数据万方数据万方数据万方数据中国鲍曼不动杆菌感染诊治与防控专家共识作者:陈佰义, 何礼贤, 胡必杰, 倪语星, 邱海波, 石岩, 施毅, 王辉, 王明贵, 杨毅, 张菁, 俞云松作者单位:陈佰义(中国医科大学第一附属医院, 沈阳,110001), 何礼贤,胡必杰(复旦大学附属中山医院), 倪语星(上海交通大学附属瑞金医院), 邱海波,杨毅(东南大学附属中大医院), 石岩(北京协和医院), 施毅(南京军区总医院), 王辉(北京大学人民医院), 王明贵,张菁(复旦大学附属华山医院), 俞云松(浙江大学医学院附属邵逸夫医院)刊名:中华医学杂志英文刊名:National Medical Journal of China年,卷(期):2012,92(2)被引用次数:31次1.Peleg AY;Seifert H;Paterson DL Acinetobacter baumannii:emergence of a successful pathogen[外文期刊] 2008(3)2.Falagas ME;Koletsi PK;Bliziotis IA The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR)Acinetobacter baumannii and Pseudomonas aeruginosa 20063.Paterson DL;Doi Y A step closer to extreme drug resistance (XDR) in gram-negative bacilli 20074.Falagas ME;Karageorgopoulos DE Pandrug resistance (PDR),extensive drug resistance (XDR),and multidrug resistance (MDR) among Gram-negative bacilli:need for international harmonization in terminology 20085.Zhou H;Yang Q;Yu YS Clonal Spread of Imipenemresistant Acinetobacter baumannii among different cities of China[外文期刊] 20076.Perez F;Hujer AM;Hujer KM Global challenge of multidrug-resistant Acinetobacter baumannii 20077.Munoz-Price LS;Robert AW Acinetobacter Infection 20088.Guardado AR;Blanco A;Asensi V Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters:assessment of different treatments[外文期刊] 2008(4)9.Lenie D;Alexandr N;Harald S An increasing threat in hospitals:multidrug-resistant Acinetobacter baumannii 200710.杨启文;王辉;徐英春腹腔感染细菌流行病学调查 200911.Falagas ME;Karveli EA;Kelesidis I Community-acquired Acinetobacter infections[外文期刊] 200712.Galani I;Flora K;Maria S Colistin susceptibility testing by Etest and disk diffusion methods[外文期刊] 2008(5)13.Zhou H;Zhang T;Yu D Genomic analysis of the multidrug resistant Acinetobacter baumannii strain MDR-ZJ06 widely spread in China 201114.Bergogne E;Towner KJ Acinetobacter spp. as Nosocomial Pathogens: Microbiological, Clinical, and Epidemiological Features 1996 Scola B;Gundi VA;Khamis A Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species 200616.Turton JF;Woodford N;Glover J Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species[外文期刊] 200617.Ecker JA;Massire C;Hall TA Identification of Acinetobacter species and genotyping ofAcinetobacter baumannii by multilocus PCR and mass spectrometry 200618.Higgins PG;Wisplinghoff H;Krut O A PCR based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU[外文期刊] 2007(12)19.Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, Sixteenth Informational Supplement 201120.Fishbain J;Peleg AY Treatment of Acinetobacter infections[外文期刊] 201021.Garnacho-Montero J;Amaya-Villar R Multiresistant Acinetobacter baumannii infections:epidemiology and management 201022.Neonakis IK;Spandidos DA;Petinaki E Confronting multidrugresistant Acinetobacter baumannii:a review[外文期刊] 201123.Jian Li;Craig RR;Roger LN Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii 200624.Waites KB;Duffy LB;Dowzicky MJ Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline,a new glycylcycline antimicrobial[外文期刊] 200625.Navon-Venezia S;Leavitt A;Carmeli Y High tigecycline resistance in multidrug-resistant Acinetobacter baumannii[外文期刊] 200726.Lee NY;Wang CL;Chuang YC Combination carbapenemsulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia:four case reports and an in vitro combination synergy study 200727.Kiffer CR;Sampaio JL;Sinto S In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii 200528.Petrosillo N;Ioannidou E;Falagas ME Colistin monotherapy bination therapy:evidence from microbiological,animal and clinical studies[外文期刊] 2008(9)29.Sopirala MM;Mangino JE;Gebreyes WA Synergy testing by Etest,microdilution checkerboard,and time-kill methods for pan-drug-resistant Acinetobacter baumannii[外文期刊] 201030.Entenza JM;Moreillon P Tigecycline in combination with other antimicrobials:a review of in vitro, animal and case report studies[外文期刊] 200931.Petersen PJ;Labthavikul P;Jones CH In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis 200632.Jennifer HM;Marina H;Paul H Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production 201033.Luna CM;Aruj PK Nosocomial Acinetobacter pneumonia[外文期刊] 2007(6)34.Towner KJ Acinetobacter:an old friend,but a new enemy 200935.Hilmar W;Michael B;Edmond MA Nosocomial bloodstream infections caused by Acinetobacter species in united states hospitals:clinical features,molecular epidemiology,and antimicrobial susecptibility 200036.Trottier V;Namias N;Pust DG Outcomes of Acinetobacter baumannii infection in critically ill surgical patients 200737.Rodriguez-Bano J;Cisneros JM;Fernandez-Cuenca F Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals[外文期刊] 2004(10)38.桑福德;范宏伟热病:《桑福德抗微生物治疗指南》(新译第39版) 201139.Mermel LA;Allon M;Bouza E Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection:2009 update by the infectious diseases society of America 200940.中华医学会重症医学分会血管内导管相关感染的预防与治疗指南(2007) 200841.Lemuel LDent;Dana RM;Siddharth P Multidrug resistant Acinetobacter baumannii:a descriptive study in a city hospital[外文期刊] 201042.Solomkin JS;Mazuski JE;Bradley JS Diagnosis and management of complicated intra-abdominal infection in adults and children:guidelines by the Surgical Infection Society and the Infectious Diseases Society of America 201043.Akkoyun S;Kuloglu F;Tokuc B Etiologic agents and risk factors in nosocomial urinary tract infections 200844.Hooton TM;Bradley SF;Cardenas DD Diagnosis,prevention,and treatment of catheter-associated urinary tract infection in adults:2009 international clinical practice guidelines from the infectious diseases society of America[外文期刊] 201045.Tenke P;Kovacs B;Bjerklund Johansen TE European and Asian guidelines on management and prevention of catheterassociated urinary tract infections 200846.Petersen K;Riddle MS;Danko JR Trauma-related infections in battlefield casualties from Iraq[外文期刊] 200747.Murray CK Acinetobacter skin carriage among US army soldiers deployed in Iraq 200748.中国医师协会皮肤科分会皮肤软组织感染诊断和治疗共识 200949.Corradino B;Toia F;Di Lorenzo S A difficult case of necrotizing fasciitis caused by Acinetobacter baumannii[外文期刊] 201050.Duan X;Yang L;Xia P Septic arthritis of the knee caused by antibiotic-resistant Acinetobacter baumannii in a gout patient:a rare case report[外文期刊] 2010chanas E;Tomos P;Sfyras N Acinetobacter baumannii mediastinitis after cardiopulmonary bypass:case report and literature review 200852.Tekce Ay;Erbay A;Cabadak H Pan-resistant Acinetobacter baumannii mediastinitis treated successfully with tigecycline:acase report 201153.Schafer J;Mangino Je Multidrug-resistant Acinetobacter baumannii osteomyelitis from Iraq[外文期刊] 200854.Marioni G;Marchese-Ragona R;Boldrin C Deep neck absess due to Acinetobacter baumannii infection[外文期刊] 201055.Aivazova V;Kainer F;Friese K Acinetobacter baumaonii infection during pregnancy and puerperium[外文期刊] 201056.Boyce JM;Pittet D Guideline for Hand Hygiene in Health Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force 200257.Pittet D;Allegranzi B;Boyce J The World Health Organization Guidelines on Hand Hygiene in Health Care and their consensus recommendations[外文期刊] 2009(7)1.骆松梅.廖彩霞.叶鸿斌.刘敏鲍氏不动杆菌耐药与抗菌药物使用强度的相关性分析[期刊论文]-中华医院感染学杂志 2013(13)2.瞿嵘.郭智.凌云.纪妍替加环素联合美罗培南治疗广泛耐药鲍曼不动杆菌感染的临床分析[期刊论文]-中国医药 2013(8)3.于国平神外病区多重耐药鲍曼不动杆菌医院感染暴发调查与控制[期刊论文]-中国消毒学杂志 2013(8)4.刘玉岭.张会平.丁真.宋红岩.史广鸿2006~2011年鲍曼不动杆菌耐药性变迁[期刊论文]-中华全科医学 2013(7)5.高世华.池细俤.陈家龙.李国玉.吕春燕CHROM-agar产色平板在MDRAB快速检测的应用研究[期刊论文]-中国实验诊断学 2013(5)6.于亮.王梅三种碳青霉烯类抗菌药物联用头孢哌酮舒巴坦对耐碳青霉烯鲍曼不动杆菌的抗菌活性分析[期刊论文]-中华实验和临床感染病杂志(电子版) 2013(6)7.池细?.高世华.陈家龙.李国玉.林蓉金.胡望平.张永平多重耐药鲍曼不动杆菌随机多态性DNA分型与院内感染相关性研究[期刊论文]-中国人兽共患病学报 2013(6)8.甘井山.刘秀书.隋洪飞我院住院患者抗菌药物使用情况调查分析[期刊论文]-天津药学 2013(1)9.李裕军.潘楚芝.赵子文.陈惠玲.赵祝香.卢伟波.叶惠芬鲍曼不动杆菌常用药物敏感性试验方法之间的差异比较[期刊论文]-实用医学杂志2013(1)10.屈振东.宛传丹常熟地区鲍曼不动杆菌临床感染分布及耐药性监测[期刊论文]-检验医学与临床 2013(18)11.于翠香.傅爱玲.王均玲.王英田.周玲多重耐药鲍曼不动杆菌耐药相关基因的样本聚类分析[期刊论文]-中国抗生素杂志 2013(4)12.凌玲.孙树梅.汪能平.向前.周浩.王茵茵鲍曼不动杆菌所致呼吸机相关性肺炎危险因素及疾病经济负担[期刊论文]-中国感染控制杂志2013(6)13.王飞.姚贝.张捷.贺蓓鲍氏不动杆菌及铜绿假单胞菌肺炎患者死亡相关危险因素分析[期刊论文]-中华医院感染学杂志 2013(6)14.林孟相.郭蕾.郭献阳.庄荣.金胜威.应斌宇替加环素联合头孢哌酮/舒巴坦治疗泛耐药鲍氏不动杆菌感染临床疗效观察[期刊论文]-中华医院感染学杂志 2013(8)15.于亮.王梅亚胺培南联合头孢哌酮/舒巴坦对耐碳青霉烯鲍曼不动杆菌的抗菌作用[期刊论文]-中华传染病杂志 2013(7)16.徐晓晓.林立.张慧玲.李昌崇174株鲍曼/醋酸钙不动杆菌复合体临床分布及耐药性分析[期刊论文]-医学研究杂志 2013(12)17.陈爱玲.陈建.张金兰临床药师参与药物治疗实践回顾与体会[期刊论文]-中国卫生产业 2013(24)18.黄芸耐碳青霉烯鲍曼不动杆菌的耐药分析[期刊论文]-上海预防医学 2013(4)19.林永棠临床药师参与胫骨平台骨折术后感染的治疗分析[期刊论文]-中国药物警戒 2013(9)20.戴燕鸣34例鲍曼不动杆菌阳性患者耐药及抗菌药物使用情况分析[期刊论文]-医药前沿 2012(15)21.周朝阳.周建英鲍曼不动杆菌呼吸机相关性肺炎的危险因素分析[期刊论文]-中国微生态学杂志 2013(6)22.黄何清.王琴.周祖模.黄富礼诸暨市人民医院鲍氏不动杆菌的临床分布与耐药分析[期刊论文]-国际流行病学传染病学杂志 2013(1)23.倪菊平.余跃天.沈国锋.刘春艳.李响.邓星奇呼吸机相关性肺炎患者鲍曼不动杆菌的分离率和耐药性变迁[期刊论文]-中国医师进修杂志2013(16)24.潘楚芝.李裕军.赵子文.陈惠玲.赵祝香.卢伟波.叶惠芬纸片扩散法与微量肉汤稀释法检测鲍曼不动杆菌对替加环素体外敏感性的比较[期刊论文]-广东医学 2013(14)25.于亮.王梅.姜梅杰.李玉臣.刘爱华药物对美罗培南抑制耐碳青霉烯类抗菌药物鲍曼不动杆菌的影响[期刊论文]-中华实验和临床感染病杂志(电子版) 2012(6)26.戴燕鸣.刘文娟6种特殊使用级抗菌药物用药频度和使用强度与医院内部分病原菌耐药率的相关性分析[期刊论文]-中国药业 2012(24)27.梁伟.邹明祥.邬靖敏.邬国军.李军.豆清娅.刘文恩长沙地区临床分离碳青霉烯类耐药鲍曼不动杆菌的分子流行病学特征[期刊论文]-中南大学学报(医学版) 2012(5)28.田泾.王学彬.钱皎.高申.王卓28例肾移植术后肺部感染患者的药物治疗分析[期刊论文]-药学服务与研究 2013(4)29.林筱琦.沈静.贾民2011-2012年重症医学科抗菌药物使用与细菌耐药性分析[期刊论文]-新疆医科大学学报 2013(7)30.徐玲.李晓华.徐红冰药师参与替加环素治疗耐多药鲍曼不动杆菌肺部感染2例的体会[期刊论文]-中国医院用药评价与分析 2013(11)31.李贤文.郑健临床药师参与1例老年社区获得性肺炎抗感染治疗的病例分析[期刊论文]-医学信息 2013(24)32.陈姝.戎光.杨志旭.李洁综合ICU病原菌的分布及耐药性分析[期刊论文]-南昌大学学报(医学版) 2012(7)33.公衍文.薛炼.李继霞碳青霉烯类耐药鲍曼不动杆菌对其他抗菌药物的非耐药模式[期刊论文]-国际检验医学杂志 2012(20)34.谭建龙.张卫东.柳威.刘志光.李文朴.江刚替加环素治疗多或泛耐药鲍曼不动杆菌肺炎的疗效观察[期刊论文]-中国呼吸与危重监护杂志2013(6)35.宁红.罗军.李红霞2012年绵阳市中心医院临床常见细菌耐药性监测[期刊论文]-中国医院用药评价与分析 2013(11)36.王实慧.曹力.余晓耕.钟海利.章新晶.梅竹君1例老年重症感染患者诊疗中的药学监护报告[期刊论文]-江西医药 2013(5)37.袁雅冬.宫小薇.于婧2012年呼吸病学的部分进展[期刊论文]-临床荟萃 2013(6)38.亓梅.韩其政.贾曰林替加环素治疗泛耐药鲍曼不动杆菌肺部感染1例[期刊论文]-中国感染与化疗杂志 2013(3)39.周朝阳.陈增瑞.郑孝敬.林美爱.章林华综合干预措施对鲍曼不动杆菌呼吸机相关性肺炎的影响[期刊论文]-全科医学临床与教育 2013(2)40.刘琳.董琳.徐月波.陈兆兴.樊节敏儿童侵袭性鲍曼不动杆菌感染的临床特征和耐药分析[期刊论文]-中国当代儿科杂志 2013(5)41.王晓东.王俊平.李争艳呼吸机相关性肺炎的病原菌综合感染分析[期刊论文]-中华医院感染学杂志 2013(8)42.张辉.冯明亮重症监护病房脑出血患者院内感染现状分析[期刊论文]-中国医师进修杂志 2013(17)43.童孜蓉.张程.宋燕波神经外科重症患者鲍曼不动杆菌感染的护理体会[期刊论文]-江苏医药 2013(14)44.张晓曼.罗小娜.娄萍.李艾帆.逄涛.许予明.张慧萍脑梗死机械通气患者呼吸机相关肺炎病原学及相关因素分析[期刊论文]-中华老年心脑血管病杂志 2013(11)45.王实慧.曹力.余晓耕.钟海利.章新晶.梅竹君1例老年重症感染患者诊疗中的药学监护报告[期刊论文]-江西医药 2013(5)46.鄂桂香.刘英.梁华鲍曼不动杆菌感染患者的药学监护[期刊论文]-抗感染药学 2013(2)47.王娟.王磊.李志奎.宋立强.张方琪.唐元元综合性医院ICU鲍曼不动杆菌分布及耐药性变迁分析[期刊论文]-中华肺部疾病杂志(电子版) 2013(5)48.范秀.潘海燕.汪得喜鲍曼不动杆菌耐消毒剂基因检测及同源性和耐药特征分析[期刊论文]-医学与哲学 2013(12)49.徐红冰.刘皋林.王晓平中枢神经系统感染的药物治疗现状[期刊论文]-世界临床药物 2013(1)50.乔莉.张劲松.梅亚宁.张华忠.苏成磊鲍曼不动杆菌血流感染预后的危险因素分析[期刊论文]-中华危重病急救医学 2013(8)51.吴春阳.钱雪峰.顾国浩多重耐药鲍曼不动杆菌碳青霉烯酶基因型研究[期刊论文]-国际检验医学杂志 2013(13)52.李茉莉.潘频华.胡成平呼吸ICU医院获得性肺炎的病原学分布与致病菌耐药性的变迁[期刊论文]-中南大学学报(医学版) 2013(3)53.石岩.徐英春.刘晔.杜微.芮曦.王瑶头孢哌酮-舒巴坦联合米诺环素治疗广泛耐药鲍曼不动杆菌感染[期刊论文]-中华医学杂志 2012(40)54.唐震海.胡钱红.麦菁芸.柳艳丽.俞丽君.彭慈爱.林振浪.林锦新生儿重症监护病房鲍曼不动杆菌感染的临床调查与耐药现状[期刊论文]-中国新生儿科杂志 2013(3)55.王霞.徐敏.陈淑君预防呼吸机相关性肺炎的循证护理实践[期刊论文]-医学信息 2013(4)56.陈志东实施《抗菌药物临床应用管理办法》对药师职业定位的思考[期刊论文]-上海医药 2012(15)57.中国医师协会急诊医师分会2013中国急诊急性胰腺炎临床实践指南[期刊论文]-中国急救医学 2013(12)58.中华医学会重症医学分会呼吸机相关性肺炎诊断、预防和治疗指南(2013)[期刊论文]-中华内科杂志 2013(6)本文链接:/Periodical_zhyx201202002.aspx。
坏死性筋膜炎-Necrotizing-Fasciitis

Clinical Features
Noninvasive disease:链球菌性喉炎,脓疱病 Invasive disease:坏死性筋膜炎(NF)、链球菌中
毒性休克综合征(STSS)、蜂窝组织炎、菌血症、 肺炎、产后脓毒病 Nonsuppurative sequelae:急性风湿热、链球菌感 染后肾小球肾炎
➢ 食萄—球G肉-菌:菌、大真肠肠实球杆面菌菌目、为铜绿GA假S单,胞是菌非常普遍存在的细菌 ➢ N—F厌也氧早菌在:一拟杆个菌世属纪、前梭就菌见属、诸产报气道荚膜杆菌(罕见) ➢ 死对亡所率有取药决物于合耐并药症,情也况是媒体编造出来的事实
NF分型及病因
第二种类型:单细菌型。 20%-30%的NF属于此类型。多见于免疫功能正常的年轻人 多发生于四肢部位
细胞壁成分
透明质酸酶;
链激酶,又称链球菌溶纤维蛋白酶;
链道酶,又称脱氧核糖核酸酶; 链球菌溶血素,主要有“O”和“S”两种;
侵袭性酶
致热外毒素(SPE),又称红疹毒素或猩红热毒素 外毒素类
GAS分型
链球菌抗原类型
核蛋白抗原(p抗原):无特异性,各种链球菌均相 同,与葡萄球菌有交叉
定义
发Байду номын сангаас部位
—上肢(10%-48%) —下肢(28%) —会阴部(Fournier坏疽, 21%) —躯干(18%) —头颈(5%)
A—群—链食N球肉F菌菌分(G型ro及up病A S因treptococcus, GAS)
➢ 1994年5月,从英国格罗斯特郡开始爆发GAS感染导 致NF的病例
➢ 英国各大媒体纷纷头条报道:“Deadly virus baffles doctors”“Killer bug ate my face”
1例肛周坏死性筋膜炎外科清创后的伤口护理

1例肛周坏死性筋膜炎外科清创后的伤口护理发布时间:2021-11-25T15:44:16.311Z 来源:《医师在线》2021年7月13期作者:吕瑶[导读]吕瑶(新疆维吾尔自治区中医医院;新疆乌鲁木齐830000)摘要:坏死性筋膜炎 ( necrotizing,fasciitis,NF) 是一种较为少见的会威胁生命的进行性感染疾病,皮下组织和筋膜受到细菌的攻击时,造成的急性坏死性软组织感染,具有发病较为迅速、起病急、破坏力强、病亡率高等特点,死亡率大约 12% ~ 35%[1]。
本案例因医疗环境和患者身体因素影响,无法及时接受手术,只做了普通外科清创和换药处理,最后患者病情好转出院。
现将此案例的一些护理经验和体会记录下来,与各位同仁交流与共享。
关键字:坏死性筋膜炎;氧疗;伤口护理;中药湿敷中图分类号:R473.6文献标识码:A坏死性筋膜炎(necrotizing fasciitis, NF)作为一种临床罕见的重症感染性疾病,一般发生于腹部、会阴部等皮下软组织较为疏松的部位,如发于肛周,为肛周坏死性筋膜炎[2]。
及时行外科手术,广泛扩大清除所有坏死组织及可疑感染组织是坏死性筋膜炎的治疗原则[3],但在医疗环境和患者身体因素的局限下,只做了普通外科清创。
1病例资料赵某,男,44岁,因“肛周肿痛不适5天,加重1天”于 2019 年 8月 5日收治入院。
患者入院5天前无明显诱因出现肛周肿痛不适,自觉发热,曾来我院测体温为39.8℃,故发热门诊留观三天,予以金黄膏外敷肛门疼痛区,并口服乳果糖后自觉疼痛较前改善,体温正常后回家。
2019年8月4日患者如厕出现肛周破溃,破溃口流出较多脓血,患者自觉肛门疼痛加重,8月5日晨起肿痛延至阴囊,故再次来院求治,由急诊“肛周脓肿“收住入院。
患者入院后完成了相关常规检查:血便常规、尿液分析+尿沉渣、凝血+D2聚体、血型测定、肝功、肾功、电解质、心电图、肺部CT、甲乙丙肝艾滋梅毒、心脏彩超、睾丸及附睾彩超以了解病情。
坏死性筋膜炎常见并发症的预防及护理

坏死性筋膜炎常见并发症的预防及护理[摘要]目的观察坏死性筋膜炎常见并发症发生情况,探究其预防和护理措施。
方法选取2021年7月~2022年5月在我院进行治疗的56例坏死性筋膜炎患者展开本次实验研究,观察其发生感染、贫血等并发症的情况,分析总结预防并发症的对策和护理措施。
结果在治疗期间出现并发症的患者总计有44例,发生率高达78.57%,包括低蛋白血症、贫血等;在治疗和护理后,除5例患者病情恶化放弃治疗出院,其余51例患者均已痊愈出院。
结论坏死性筋膜炎有着较高的并发症发生率,应予以抗休克治疗和营养支持等有效并发症预防护理措施,达到预防、减少并发症目的,提高临床疗效。
[关键词]坏死性筋膜炎;并发症;预防;护理[Abstract] Objective To observe the common complications of necrotizing fasciitis and explore the prevention and nursing measures. Methods Fifty-six patients with necrotizing fasciitis treated in our hospital from July 2021 to May 2022 were selected for this experimental study. The incidence of complications such as infection and anemia was observed, and the countermeasures and nursing measures to prevent complications were analyzed and summarized. Results A total of 44 patients had complications during the treatment, the incidence rate was 78.57%, including hypoproteinemia, anemia, etc. After treatment and nursing, except for 5 patients who gave up treatment and discharged from hospital, the remaining 51 patients were cured and discharged. Conclusions Necrotizing fasciitis has a high incidence of complications. Effective preventive nursing measures such as anti-shock therapy and nutritional support should be taken to prevent and reduce complications and improve clinical efficacy.[Key words] Necrotizing fasciitis; Complications; Prevention; nursing坏死性筋膜炎指的是患者皮下组织、筋膜受到链球菌和金黄色葡萄球菌等多种细菌侵袭导致的软组织感染性疾病,皮肤损伤以及术后损伤等均可导致坏死性筋膜炎的发生,发病部位多为四肢、肛周等。
fatalcaseduetome...

Staphylococcus aureus causes acute and often fatal infections. Small colony variants (SCVs), which are subpopulations of S. aureus,are implicated in persistent and recurrent infections (in particular osteomyelitis, septic arthritis, respiratory tract infections in patients with cystic fibrosis, and deep-seated abscesses)(1-4). These phenotypic variants produce small,slow-growing, nonpigmented, nonhemolytic colo-nies on routine culture media, making correct identification difficult for clinical laboratories.Biochemical characterization of these variants suggests that they are deficient in electron transport activity (5). We report a fatal case of a persistent deep-seated hip abscess due to methicillin-resistant S. aureus SCVs that led to osteomyelitis and bloodstream infection in a patient with AIDS.Case ReportA 36-year-old man with AIDS came to the Cologne University Hospital, Cologne, Germany,in June 1997 with fever and progressive pain (of 6 weeks duration) in his right hip. HIV infection had been diagnosed in 1986. In 1994, his CD4 cell count was 250/µL, and oral zidovudine therapy was started. His medical history included Pneumocystis carinii pneumonia, pulmonary tuberculosis, and recurrent oral thrush; his medication included zidovudine, lamivudine,fluconazole, and trimethoprim/sulfamethoxazole.In September 1996, he was in a traffic accident and had severe cerebral trauma resulting in spastic hemiparesis with occasional seizures.After an intramuscular injection 2 months before admission, pus was surgically drained to treat recurrent abscesses of his right hip. Specimens for culture were not obtained.Physical examination found limited mobility of his right thigh and a tender, nondraining scar at the site of surgical drainage. Neither warmth nor swelling was observed over his right hip.Vital signs were temperature, 38.2°C; respira-tion rate, 28; and heart rate, 108. He was awake and alert and had spastic paresis in his right boratory studies performed on admission showed hemoglobin, 10.8 g/dL; leukocyte count,3,000/µL with a normal differential; CD4 cell count, 20/µL; platelet count, 131,000/µL;C-reactive protein, 184 mg/L; and alkaline phosphatase, 1490 U/L. Radiographs of the chest and a plain film of the pelvis were normal. A triple-phase bone scan showed an area of minor tracer accumulation in the acetabulum region of the right hip. Blood cultures were drawn, but antimicrobial therapy was withheld until culture results became available.On hospital day 2, one of two blood cultures drawn on admission yielded nonhemolytic staphylococci that were clumping factor negative. The organisms were initially misidentified as coagulase-negative staphylo-cocci and were considered contaminants.Fatal Case Due to Methicillin-ResistantStaphylococcus aureus Small ColonyVariants in an AIDS PatientHarald Seifert,* Christoph von Eiff, and Gerd Fätkenheuer *University of Cologne, Cologne, Germany; and Westfälische Wilhelms-Universität, Münster, GermanyAddress for correspondence: Harald Seifert, Institute of Medical Microbiology and Hygiene, University of Cologne,Goldenfelsstraße 19-21, 50935 Cologne, Germany; fax: 49-221-478-3081;e-mail:***************************.We describe the first known case of a fatal infection with small colony variants ofmethicillin-resistant Staphylococcus aureus in a patient with AIDS. Recovered fromthree blood cultures as well as from a deep hip abscess, these variants may haveresulted from long-term antimicrobial therapy with trimethoprim/sulfamethoxazole forprophylaxis of Pneumocystis carinii pneumonia.Figure 1. Staphylococcus aureus small colony variants (A) and S. aureus with a normal phenotype (B) cultured on sheep blood agar after 24 hours of incubation at 35°C. Staphylococci were identified by conventional methods (6) and with the ID 32 Staph system (bioMérieux, Marcy-L Etoile, France) follow-ing the instructions of the manufacturer. The tube-coagulase test was read after 24 hours. S. aureus isolates were characterized as small colony variants as described before (7-8). Auxotrophic requirements were evaluated with 10-µg hemin disks, 1.5-µg menadione disks, and 1.5-µg thymidine disks on Mueller-Hinton agar and on chemically defined medium (CDM) agar as well as on CDM agar supplemented with 1 µg/mL hemin, 100 µg/mL thymidine, and 1 µg/mL menadione, respectively.Empiric antistaphylococcal therapy with clindamycin (600 mg q8hr) was instituted. On hospital day 4, two sets of blood cultures obtained on hospital day 2 yielded phenotypically identical organisms, which on the basis of a positive tube coagulase test were identified as oxacillin-resistant S. aureus. The colony mor-phology was suggestive of an SCV of S. aureus .The patient was started on parenteral vancomy-cin treatment (1 g q12hr). However, his condition deteriorated rapidly, and he died of refractory septic shock 6 days after admission.Autopsy showed a large (12 x 10 x 8 cm),deep-seated abscess of the right hip and osteomyelitis of the ischial tuberosity. Both SCVs and typical large colony forms of S. aureus were cultured from postmortem specimens of the abscess and the bone.FindingsS. aureus SCVs were recovered from one of two blood culture sets obtained on admission and from two of four blood culture sets obtained on hospital day 2. Growth was not detected until the blood culture bottles had been incubated 24hours. S. aureus with a normal phenotype was recovered from nose and throat specimens but not from blood cultures, whereas both SCVs and typical S. aureus phenotypes were isolated from the deep hip abscess (Figure 1) before death, as well as from a postmortem specimen. All isolates were clumping factor negative but showed a delayed positive reaction in the tube-coagulase test at 24 hours. The results of the ID 32 staph test did not unambiguously identify SCVs as S. aureus because the tests for urease and trehalose were negative. Both the nuc gene and the coa gene were identified by polymerase chain reaction (PCR) amplification. Methicillin resis-tance was confirmed for both small and large colony forms by PCR amplification of the mecA gene.When cultured without supplementation, all SCVs were nonpigmented and nonhemolytic.Supplementation with hemin, thymidine, or menadione identified two SCVs showing thymi-dine auxotrophy and a combined thymidine and menadione auxotrophy, respectively. All SCVs were stable on repeated subculturing.Epidemiologic typing by PCR analysis of inter-IS256 spacer length polymorphisms (Fig-ure 2) and pulsed-field gel electrophoresis of genomic DNA (data not shown) showed identical banding patterns for both SCVs and large colony forms, which indicates that the phenotypically different S. aureus isolates represented a single strain. Antimicrobial susceptibility testing was performed by microbroth dilution, according to the National Committee for Clinical Laboratory Standards guidelines. Susceptibility to trimethoprim/sulfamethoxazole was tested with Etest (AB Biodisk, Solna, Sweden). In contrast to current standards, the MICs for SCVs were determined after 48 hours of incubation at 35°C.Susceptibility testing showed that all S. aureus isolates were resistant to penicillin (MIC, >8 µg/mL), ampicillin (MIC, >32 µg/mL), oxacillin (MIC, >8 µg/mL), erythromycin (MIC, >32 µg/mL),clindamycin (MIC, >32 µg/mL), ciprofloxacin (MIC, >8 µg/mL), gentamicin (MIC, >500 µg/mL),and trimethoprim/sulfamethoxazole (MIC,>32 µg/mL) and susceptible to vancomycinFigure 2. Fingerprint patterns obtained for Staphylococcus aureus small colony variants (lanes 3-5, bloodculture isolates; lanes 6 and 7, isolates from hip abscess; lane 8, postmortem specimen) and S.aureus isolates with a normal phenotype (lanes 10and 11, isolates from nose and throat; lanes 12 and 13, isolates from hip abscess and postmortem specimen) after polymerase chain reaction (PCR)analysis of inter-IS256 spacer length showing identical strains. Lane 1, 100-bp ladder; lanes 2, 9,and 16, methicillin-resistant S. aureus (MRSA)reference strain; lanes 14 and 15, epidemiologically unrelated MRSA strains. Strain relatedness of all isolates with different colony morphologies and from different sources was analyzed by PCR analysis of inter-IS256 spacer length polymorphisms (9) and pulsed-field gel electrophoresis after Sma I restric-tion (8). Minor modifications included the use of brain heart infusion broth instead of trypticase soy broth to obtain sufficient growth of S. aureus small colonyvariants.(MICs, 1-2 µg/mL), teicoplanin (MICs,0.5-1 µg/mL), and quinupristin/dalfopristin (MICs, 0.5-1 µg/mL). No differences in MICs were observed between S. aureus SCVs and S.aureus isolates with normal phenotype.To our knowledge, this case represents the first of a serious S. aureus infection in an AIDS patient in which all blood cultures yielded SCVs.The SCVs unusual morphologic appearance and slow growth delayed the correct identifica-tion of these organisms as S. aureus . The empiric antimicrobial regimen in our patient did not include a glycopeptide, because of the low rate of methicillin resistance in commu-nity-acquired S. aureus infection in Germany.Appropriate antistaphylococcal therapy was,therefore, not started until hospital day 4.Delayed antimicrobial therapy on day 4 rather than on day 2 may have contributed to the patient s death.Proctor and colleagues recently reported five cases in which SCVs of S. aureus were implicated in persistent and relapsing infections. They identified only a single case reported in the previous 17 years and ascribed this to insufficient ability of laboratories to identify these organisms (8). In most cases, patients had received antibiotics. Aminoglycoside treatment may have selected for S. aureus SCVs (10), and in cases of osteomyelitis or deep-seated abscesses,persistence of these variants in the intracellular milieu may have permitted evasion of host defenses and allowed for the development of resistance to antimicrobial therapy (7,11). Von Eiff and colleagues recently reported four cases of chronic osteomyelitis due to SCVs of S. aureus in patients who had received gentamicin beads as an adjunct to surgical therapy for osteomyeli-tis (2). Kahl et al. described persistent infection with S. aureus SCVs in patients with cystic fibrosis (4). All these patients had received long-term trimethoprim/sulfamethoxazole prophy-laxis. It may be tempting to speculate that administration of trimethoprim/sulfamethoxazole for prophylaxis against P. carinii pneumonia may have selected for SCVs within the patient s large hip abscess. Further prospective studies are needed to assess the role of S. aureus SCVs in HIV-infected patients on long-term antimicro-bial therapy.Dr . Seifert is assistant professor at the Institute of Medical Microbiology and Hygiene, University of Co-logne, Germany . His research interests include the mo-lecular epidemiology of nosocomial pathogens, in par-ticular Acinetobacter species, catheter-related infections,and antimicrobial resistance.References 1.Proctor RA, Balwit J M, Vesga O. Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. Infectious Agents and Disease 1994;3:302-12. 2.von Eiff C, Bettin D, Proctor RA, Rolauffs B, Lindner N,Winkelmann W, et al. Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin Infect Dis 1997;25:1250-1. 3.Spearman P, Lakey D, J otte S, Chernowitz A, Claycomb S, Stratton C. Sternoclavicular joint septic arthritis with small colony variant Staphylococcus aureus .Diagn Microbiol Infect Dis 1996;26:13-5. 4.Kahl B, Herrmann M, Everding AS, Koch HG, Becker K, Harms E, et al. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis 1998;177:1023-9.5.von Eiff C, Heilmann C, Proctor RA, Woltz C, Peters G,Götz F. A site-directed Staphylococcus aureus hemB mutant is a small colony variant which persists intracellularly. J Bacteriol 1997;179:4706-12.6.Kloos WE, Bannerman TL. Staphylococcus andmicrococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. 6th ed. Washington: American Society for Microbiology; 1995. p. 282-98.7.Balwit JM, van Langevelde P, Vann JM, Proctor RA.Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J Infect Dis 1994;170:1033-7. 8.Proctor RA, van Langevelde P, Kristjansson M, MaslowJ N, Arbeit RD. Persistent and relapsing infections associated with small colony variants of Staphylococcus aureus. Clin Infect Dis 1995;20:95-102.9.Deplano A, Vaneechoutte M, Verschraegen G, StruelensMJ. Typing of Staphylococcus aureus and Staphylococcus epidermidis by PCR analysis of inter-IS256 spacer length polymorphisms. J Clin Microbiol 1997;35:2580-7.10.Pelletier LL J r, Richardson M, Feist M. Virulentgentamicin-induced small colony variants of Staphylococcus aureus. J Lab Clin Med 1979;94:324-34.11.Proctor RA, Kahl B, von Eiff C, Vaudaux PE, Lew DP,Peters G. Staphylococcal small colony variants have novel mechanisms for antibiotic resistance. Clin Infect Dis 1998;27 Suppl 1:S68-74.。
Necrotizing fasciitis

AT LAST I WANT TO TELL EVERYONE, STAY HOME AND HAVE A CALM HEART THANK FOR WATCHING!
EXAMPLE
PROTECTIVE MEASURES
• If you want to prevent necrotizing fasciitis, you should pay attention to your diet first. You must quit smoking and alcohol, and do not eat spicy food. Instead, you should give foods with high protein and cellulose for many times. You should eat more nutritious food. Only if we absorb enough nutrients, the body's immune ability will be better. At the same time, we should also pay attention to our rest conditions, make sure that we have enough rest time, and never let ourselves be too tired. Everyone's life should be regular, not too nervous, and we must keep an optimistic attitude. In addition, we must do more physical exercises and adjust our physical condition at ordinary times. Finally, we should pay attention to keeping warm at ordinary times and never let ourselves suffer from cold. If we do this, we are unlikely to suffer from necrotizing fasciitis.
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
CASE REPORTFatal case of necrotizing fasciitis due to Myroides odoratusN.F.Crum-Cianflone •R.W.Matson •G.Ballon-LandaReceived:9April 2014/Accepted:21April 2014/Published online:8May2014ÓSpringer-Verlag Berlin Heidelberg 2014Keywords Myroides ÁLife-threatening infection ÁNecrotizing fasciitis ÁSeptic shock ÁCirrhosisIntroductionSevere skin and soft tissue infections (SSTIs),including necrotizing forms,that are monomicrobial in nature are most commonly caused by a Staphylococcus and Streptococcus species [1].Among those with underlying conditions,including cirrhosis,Gram-negative bacteriasuch as Vibrio and Aeromonas species may occasionally cause necrotizing infections [2,3].Other organisms are less commonly implicated in severe SSTIs,but their rec-ognition is important,especially when these organisms are associated with unique antimicrobial susceptibilities and potentially fatal outcomes.Flavobacterium odaratum ,reclassified in 1996based on genotypic and phenotypic data as Myroides odoratus [4],was described nearly a century ago as an avirulent organ-ism of unclear human significance [5].Since then,there are few data on the potential pathogenicity of this organism [6].Furthermore,the risk factors and clinical course of infections caused by this organism are poorly character-ized.Given the unique characteristics of this organism,including its resistance to a large number of antibiotics,further clinical data on Myroides infections are important.We present a case of rapidly fatal necrotizing fasciitis due to M.odoratus and provide a review of the literature.While the pathogenicity of Myroides sp.has previously been debated,this case and our review clearly demonstrate this organism’s virulence especially in the setting of risk factors such as cirrhosis and open wounds.Case reportA 55-year-old Caucasian female presented with leg pain and was found to be in septic shock.She had been hospi-talized a month previously for bilateral lower extremity cellulitis and open wounds,treated initially with cefazolin and subsequently with vancomycin after a wound culture showed methicillin-resistant Staphylococcus aureus (MRSA).She had previously received piperacillin-tazo-bactam and levofloxacin for a sacral wound infection.Her past medical history included cirrhosis (Child-Pugh scoreThe content and views expressed in this publication is the sole responsibility of the authors.N.F.Crum-Cianflone (&)ÁR.W.Matson ÁG.Ballon-Landa Scripps Mercy Hospital,4077Fifth Ave,San Diego,CA 92103,USA e-mail:nancy32red@Infection (2014)42:931–935DOI 10.1007/s15010-014-0626-0B)due to chronic hepatitis C virus,morbid obesity,and lymphedema.On presentation,vital signs included a blood pressure of 58/26mmHg and a temperature of34.3°C via Foley catheter measurement.Examination revealed a confused patient with multiple left lower extremity open wounds on the calf area,the largest being694cm;the right lower extremity had multiple smaller ulcerative lesions.There were initially no purpuric lesions or boratory values included a white blood count of1,100cells/mm3 with48%neutrophils and10%band forms,hemoglobin 9.0g/dL,platelets19,000/mm3,creatinine0.7mg/dL,AST 98units/L,ALT39units/L,total bilirubin3.2mg/dL,INR 3.6,positive DIC panel,and arterial lactic acid level 6.2mmol/L.The patient was intubated,received vaso-pressors,and empiric broad-spectrum antibiotics with vancomycin1g intravenously every12h,piperacillin-ta-zobactam4.5g intravenously every8h,and levofloxacin 750mg intravenously daily.Within6h of initial presentation,purpuric discoloration of her left lower extremity occurred beginning at the large open wound site.Within18h,the purpuric rash extended up to the left thigh and bullous lesions appeared,with similarfindings subsequently appearing on the right leg (Fig.1).The wounds were noteworthy for a fruity odor. Antibiotics were expanded to imipenem/cilastatin500mg intravenously every12h,daptomycin500mg intrave-nously every48h,and clindamycin900mg intravenously every8h(adjusted for a rising creatinine to1.3mg/dL), and an emergent left above the knee amputation was performed.Within12h,the right lower extremity purpuric lesions progressed and a right above the knee amputation was performed.Pathologic examination from both surger-ies revealed necrotizing fasciitis.Gram stains of blood and wound specimens revealed Gram-negative bacilli without other organisms.All blood (two sets)and wound cultures(n=3,including from the deep fascia)grew only an oxidase positive,non-fermenting Gram-negative bacillus.Antibiotics were modified to imi-penem/cilastatin500mg intravenously every8h(renally dosed)and doxycycline100mg intravenously every12h awaitingfinal identification of the organism.Vasopressors as well as mechanical ventilation were continued.Acute kidney injury due to acute tubular necrosis from sepsis worsened,and continuous hemodialysis was initiated. Despite maximum medical care,extension of the necro-tizing infection occurred into perineum and sacral/lumbar areas.The patient’s family opted for comfort care and the patient expired\48h after admission.Blood and wound culture isolates were identified as M. odoratus using manual(rapid NF Plus System TM:[99.9% probability)and automated(Becton–Dickinson Phoenix TM automated microbiology system:99%confidence)micro-biological methods.No other organisms were identified.Antibiotic susceptibility testing of the Myroides sp.inthe blood and wound cultures using the BD Phoenix auto-mated microdilution system showed resistance to amika-cin(MIC[32l g/mL),gentamicin and tobramycin(MIC[8l g/mL),aztreonam(MIC[16l g/mL),ceftri-axone(MIC[32l g/mL),ciprofloxacin(MIC[2l g/mL),tetracycline(MIC[8l g/mL),trimethoprim-sulfa-methoxazole(TMP/SMX,MIC[2/38l g/mL),and van-comycin(MIC[16l g/mL).Isolates had intermediatesusceptibility to piperacillin-tazobactam(MIC=64/4l g/mL),cefepime(MIC=16l g/mL),and imipenem/cila-statin(MIC=4–8l g/mL),and was only fully susceptibleto meropenem(MIC=2l g/mL).Review of the literatureA PubMed search of the English literature using the searchterms‘‘Flavobacterium’’or‘‘Myroides’’and‘‘necrotizingfasciitis’’,‘‘cellulitis’’,or‘‘soft tissue infection’’was con-ducted.Cases of Flavobacterium sp.were then limited tothe species of odoratum.We also utilized references ofarticles to search for additional cases.One additional case of necrotizing fasciitis and septicshock due to F.odoratum was identified[7].This case alsooccurred in a person with underlying cirrhosis,with thepatient surviving after amputation of the affected leg and aprolonged course of antibiotics[7].Six additional cases ofnon-necrotizing skin and soft tissue infections(SSTIs) Fig.1Purpuric rash on the bilateral lower extremeties due necro-tizing fasciitis caused by Myroides odoratus932N.F.Crum-Cianflone et al.were identified(Table1)[8–13].All cases(n=8)had concurrent bacteremia,except one which involved a localized soft tissue infection after a child sustained a pig bite.A second case of SSTI after pig bite due to a Fla-vobacterium sp.was identified,but the species was unknown,hence this case was not included[14].Cases predominantly occurred in adults(mean age63, range49–72years),with the most common underlying condition being cirrhosis.All infections involved the lower extremities,except two that occurred at upper body sites after trauma to these specific areas.Six of the eight cases, including our case,had a wound present before the onset of infection.Antimicrobial treatment of the Myroides sp. infection was based on antibiotic susceptibility patterns of the isolate,and most commonly utilized ciprofloxacin, imipenem/cilastatin,TMP-SMX,piperacillin or piperacil-lin/tazobactam.Most commonly a single agent was ulti-mately utilized for treatment,with the mean duration of antibiotics of25days(range14–40).The outcome was favorable in all cases except the current case. DiscussionMyroides sp.,formerly F.odoratum,was discovered in 1923within the intestines of patients,but without known pathogenicity[5].Subsequently,the organism was descri-bed as a potential‘‘opportunist pathogen’’[6],and was occasionally cultured from open,albeit uninfected,wounds [6,15].Our case demonstrates the potential explosive pathogenicity of Myroides sp.The presence of specific factors such as open wounds,underlying liver disease,and prior exposure to broad-spectrum antibiotics altering the normal gut and skinflora may be important for Myroides sp.to cause rapidly invasive infections.In summary,this report updates the older notion that Myroides is a non-pathogenic species,and may serve as an important alert regarding a potential change in the pathogenicity of the organism.Myroides sp.should be considered with other Gram-negative bacilli,such as Vibrio vulnificus and Aeromonas hydrophila,as a potential cause of necrotizing fasciitis, among persons with liver disease[2,3].Similar to these pathogens,Myroides sp.resides in water[8,12,16].The mechanism by which our patient was exposed to contam-inated water is unknown,but may have occurred within home or healthcare settings.A Myroides sp.infection has also been reported after trauma and water exposure during recent tsunamis[17].After exposure to this water-associ-ated organism,our patient may have become bacteremic with Myroides sp.from her gastrointestinal tract with subsequent seeding of her leg,or the organism may haveTable1Skin and soft tissue infections due to Myroides sp.,formerly Flavobacterium odoratumReferences Organism Diagnosis Age/sex UnderlyingconditionAntibiotic/surgical treatment OutcomeHsueh[7] F.odoratum Necrotizing fasciitis(LLE),bacteremia,septic shock 71/F Cirrhosis Amputation(above the knee),ciprofloxacin forapproximately28daysSurvivedBachman[8] F.odoratum Cellulitis(BUE),bacteremia63/M COPD,steroiduse,skinbreakdown Imipenem/cilastatin910days,then TMP-SMX914days;Recurrence wastreated with piperacillin910days,then TMP-SMXfor30daysSurvivedGreen[9M.odoratus Cellulitis(RLE),bacteremia69/M Heart disease TMP-SMX914days SurvivedMotwani[10]M.odoratus Cellulitis(RLE),bacteremia,septic shock 62/M Diabetes,openwound/ulcerCiprofloxacin and TMP-SMX(unknown duration)SurvivedBachmeyer [11]M.odoratimimus Cellulitis(RLE),bacteremia49/M Cirrhosis,traumaticwoundsImipenem/cilastatin andciprofloxacin.Ciprofloxacincontinued for21daysSurvivedBenedetti[12]M.odoratimimus Amputation site infection(UE/chest),pneumonia,bacteremia,septic shock 72/M Trauma withwoundPiperacillin/tazobactam andteicoplanin.28day antibioticcourseSurvivedMaraki[13]M.odoratimimus Cellulitis,osteolytic lesions(RLE)13/M Pig bite Ciprofloxacin920days SurvivedCurrent case M.odoratus Necrotizing fasciitis(BLE),bacteremia,septic shock55/F Cirrhosis,wound Imipenem DiedBLE bilateral lower extremity,BUE bilateral upper extremity,COPD chronic obstructive pulmonary disease,F female,LLE left lower extremity, M male,RLE right lower extremity,UE upper extremityFatal case of necrotizing fasciitis933entered through the open leg wound leading to a systemic infection.Gram-negative pathogens(e.g.,Vibrio sp.) among cirrhotic patients have been described as rapidly progressive and associated with a high mortality[2]—our case suggests that Myroide s sp.may have a similar presentation.The diagnosis of Myroides sp.is by culture.A recent study found that PCR techniques did not accelerate the diagnosis of the causative pathogen compared with cultures for SSTI cases;hence,culture remains the diagnostic test of choice[18].Microbiologic characteristics of Myroides sp.include being Gram-negative,yellow-pigmented,non-motile,obligate aerobic rods that are halotolerant,oxidase positive,and non-fermenters.Further,the organism exhibits a classic fruity smell,which was readily detected in our case both from the open leg wound and after plating on MacConkey agar.This genus was formerly F.odora-tum,but was redefined in1996by genotypic and pheno-typic criteria as M.odoratus,with a second related species of Myroides odoratimimus,a name chosen to signify the small differences between the two species[4].Given the increasing use of molecular typing/automated identification techniques and the rising number of compromised patients, the emergence of this pathogen as a cause of invasive infections may be on the horizon.Myroides sp.may not be initially considered in the differential diagnosis of SSTIs or necrotizing infections. However,early recognition is important given the need for specific antibiotic susceptibility testing and this organism’s resistance to a wide range of antibiotics[6].Broth micro-dilution is the antibiotic susceptibility of choice as disk diffusion methods are generally unreliable[19,20]. Myroides sp.are typically resistant tofirst-and second-generation cephalosporins,aminopenicillins,ampicillin/ sulbactam,aztreonam,ertapenem,colistin and polymixin B,making antibiotic treatment options challenging.Some have reported susceptibility toflouroquinolones and TMP-SMX[9,10],but this is variable and our case’s isolates were resistant.Of note,fluoroquinolone resistance has increased in the past several years and is now present in almost all bacterial species[21],including in Myroides sp. We utilized a carbapenem for treatment,but resistance has been previously described to this antibiotic in other cases due to the production of chromosome-encoded metallo-b-lactamases in both M.odoratus(TUS-1)and M.odora-timimus(MUS-1)isolates that hydrolyze penicillins, cephalosporins,axtreonam,and carbapenems[22].A KPC-2carbapenem-hydrolizing enzyme has been described[23].In summary,Myroides sp.is an emerging pathogen that can cause severe,life-threatening SSTIs,especially among adults with liver disease and open wounds.Although pre-viously described as a relatively avirulent organism,the pathogenic nature of this bacterium is demonstrated by this case of rapidly fatal necrotizing fasciitis and septic shock. Recent antibiotic usage may be an important predisposing factor due to this organism’s intrinsic resistance to most antibiotics and the concurrent loss of normalflora may allow for its unimpeded growth.Myroides sp.should be considered with SSTIs and necrotizing infections unresponsive to traditional antibiotics,and antimicrobial therapy including a carbapenem andfluoroquinolone con-sidered while awaiting identification and susceptibility results.Conflict of interest The authors have nofinancial interest in this work.All authors contributed to the content of the manuscript and concurred with the decision to submit it for publication. References1.Anaya DA,Dellinger EP.Necrotizing soft-tissue infection:diagnosis and management.Clin Infect Dis.2007;44:705–10. 2.Lee CC,Chi CH,Lee NY,Lee HC,Chen CL,Chen PL,ChangCM,Wu CJ,Ko NY,Tsai MC,Ko WC.Necrotizing fasciitis in patients with liver cirrhosis:predominance of monomicrobial Gram-negative bacillary infections.Diagn Microbiol Infect Dis.2008;62:219–25.3.Oliver JD.Wound infections caused by Vibrio vulnificus andother marine bacteria.Epidemiol Infect.2005;133:383–91.4.Vancanneyt M,Segers P,Torck U,Hoste B,Bernardet J-F,Vandamme P,Kersters K.Reclassification of Flavobacterium odoratum(Stutzer1929)Strains to a new genus,Myroides,as Myroides odoratus comb.nov.and Myroides odoratimimus sp.nov.Int J Syst Bacteriol.1996;46:926–32.5.Stutzer MJ.Zur frage uber die faulnisbakterien im darm.zen-tralblatt fur bakteriologie,parasitenkunde und infektionskran-kheiten.I Abt Originale.1923;91:87–90.6.Holmes B,Snell JJ,Lapage SP.Flavobacterium odoratum:aspecies resistant to a wide range of antimicrobial agents.J Clin Pathol.1979;32:73–7.7.Hsueh PR,Wu JJ,Hsiue TR,Hsieh WC.Bacteremic necrotizingfasciitis due to Flavobacterium odoratum.Clin Infect Dis.1995;21:1337–8.8.Bachman KH,Sewell DL,Strausbaugh LJ.Recurrent cellulitisand bacteremia caused by Flavobacterium odoratum.Clin Infect Dis.1996;22:1112–3.9.Green BT,Green K,Nolan PE.Myroides odoratus cellulitis andbacteremia:case report and review.Scand J Infect Dis.2001;33:932–4.10.Motwani B,Krezolek D,Symeonides S,Khayr W.Myroidesodoratum cellulitis and bacteremia.a case report.Infect Dis Clin Prac.2004;12:343–4.11.Bachmeyer C,Entressengle H,Khosrotehrani K,Goldman G,Delisle F,Arlet G,Grateau G.Cellulitis due to Myroides odo-ratimimus in a patient with alcoholic cirrhosis.Clin Exp Der-matol.2008;33:97–8.12.Benedetti P,Rassu M,Pavan G,Sefton A,Pellizzer G.Septicshock,pneumonia,and soft tissue infection due to Myroides odoratimimus:report of a case and review of Myroides infections.Infection.2011;39:161–5.13.Maraki S,Sarchianaki E,Barbagadakis S.Myroides odoratimi-mus soft tissue infection in an immunocompetent child followinga pig bite:case report and literature review.Braz J Infect Dis.2012;16:390–2.934N.F.Crum-Cianflone et al.14.Goldstein EJ,Citron DM,Merkin TE,Pickett MJ.Recovery of anunusual Flavobacterium group IIb-like isolate from a hand infection following pig bite.J Clin Microbiol.1990;28:1079–81.15.Davis JM,Peel MM,Gillians JA.Colonization of an amputationsite by Flavobacterium odoratum after gentamicin therapy.Med J Aust.1979;2:703–4.16.Douce RW,Zurita J,Sanchez O,Cardenas Aldaz P.Investigationof an outbreak of central venous catheter-associated bloodstream infection due to contaminated water.Infect Control Hosp Epi-demiol.2008;29:364–6.17.Ka¨llman O,Lundberg C,Wretlind B,Ortqvist A.Gram-nega-tive bacteria from patients seeking medical advice in Stockholm after the tsunami catastrophe.Scand J Infect Dis.2006;38: 448–50.18.Johnson KE,Kiyatkin DE,An AT,Riedel S,Melendez J,Zenilman JM.PCR offers no advantage over culture for micro-biologic diagnosis in cellulitis.Infection.2012;40:537–41.19.Aber RC,Wennersten C,Moellering RC Jr.Antimicrobial sus-ceptibility offlavobacteria.Antimicrob Agents Chemother.1978;14:483–7.20.Fraser SL,Jorgensen JH.Reappraisal of the antimicrobial sus-ceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing.Antimicrob Agents Chemother.1997;41:2738–41.21.Dalhoff A.Resistance surveillance studies:a multifaceted prob-lem–thefluoroquinolone example.Infection.2012;40:239–62. 22.Mammeri H,Bellais S,Nordmann P.Chromosome-encoded beta-lactamases TUS-1and MUS-1from Myroides odoratus and Myroides odoratimimus(formerly Flavobacterium odoratum), new members of the lineage of molecular subclass B1metallo-enzymes.Antimicrob Agents Chemother.2002;46:3561–7. 23.Kuai S,Huang L,Pei H,Chen Y,Liu J.Imipenem resistance dueto class A carbapenemase KPC-2in a Flavobacterium odoratum isolate.J Med Microbiol.2011;60:1408–9.Fatal case of necrotizing fasciitis935。